🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer

Recruitingn/aAges 18 Years - anyAllHerlev Hospital
NCT05438836 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Biopsy-verified anal cancer * Eligible for curative intended radiotherapy * Written and oral consent Exclusion Criteria: * Other malignant disease within the past 5 years (excluding basal cell carcinoma)
💊

What it tests

  • online adaptive radiotherapy
📍

Where

1 site
Oncology dept, Herlev and Gentofte Hospital
Herlev, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy